TrialJournal of clinical immunology2010

Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells.

Yaron Ilan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.